Organization
Beijing Tongren Hospital
12 clinical trials
2 abstracts
Clinical trial
CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia: a Prospective, Single-arm, Single-center, Phase 2 Clinical TrialStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
The Efficacy and Safety of CM310 Injection in Patients With Uncontrolled Seasonal Allergic Rhinitis Under Conventional Treatment: A Randomized, Double-Blind, Placebo-controlled Investigator Initiated Trial (IIT) StudyStatus: Completed, Estimated PCD: 2022-09-24
Clinical trial
Photobiomodulation Therapy for Idiopathic Facial Paralysis: Nonrandomized Trial ControlledStatus: Completed, Estimated PCD: 2023-02-20
Clinical trial
Efficacy of Laser Acupuncture for Idiopathic Bell's Palsy: A Randomized Controlled TrialStatus: Completed, Estimated PCD: 2024-01-01
Clinical trial
Effectiveness of Sugammadex Versus Neostigmine on the Reversal of Rocuronium-induced Neuromuscular Blockade in Patients With Myasthenia Gravis After Thoracoscopic Thymectomy: A Multicenter Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2024-10-31
Clinical trial
EFFECT-neo: A Prospective, Open-label, Multicenter Phase III Study to Evaluate Efficacy and Safety of Pembrolizumab Combined With Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCCStatus: Recruiting, Estimated PCD: 2027-04-30
Clinical trial
Efficacy and Safety of PD-1 Inhibitor Combined With Chemotherapy in Locally Advanced (III-IVB) Poorly Differentiated Head and Neck Squamous Cell Carcinoma: a Multi Cohort, Prospective Phase II StudyStatus: Not yet recruiting, Estimated PCD: 2025-10-31
Clinical trial
The Efficacy and Safety of Humanized Antibody Targeting the Interleukin-4 Receptor Alpha Subunit (IL-4Rα) in Patients With Uncontrolled Seasonal Allergic Rhinitis Under Standard Treatment： A Randomized, Double-Blind, Placebo-controlled IIT StudyStatus: Not yet recruiting, Estimated PCD: 2025-05-30
Clinical trial
A Phase Ib/II Clinical Trial of Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell LymphomaStatus: Recruiting, Estimated PCD: 2026-10-31
Clinical trial
The Effect of Berberine on the Secretion of Incretin in Normal ManStatus: Completed, Estimated PCD: 2023-04-06
Clinical trial
Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets and Calcium Hydroxybenzene Sulfonate Tablets (Doxium®) Under Fed Conditions in Chinese Healthy VolunteersStatus: Recruiting, Estimated PCD: 2023-04-01
Clinical trial
Establishment of CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With PolypsStatus: Recruiting, Estimated PCD: 2024-12-30
Abstract
Evaluating the efficacy and safety of pembrolizumab monotherapy or in combination with standard chemotherapy in the first-line treatment of locally recurrent head and neck squamous cell carcinoma in different TP53 and PI3K statuses.Org: Beijing Tongren Hospital, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China,
Abstract
Comprehensive genomic and transcriptomic profiling analysis of the recurrent gastrointestinal stromal tumor (GIST).Org: ChosenMed Technology (Zhejiang) Co., Ltd., Chinese People’s Liberation Army General Hospital, Beijing Tongren Hospital, Siping Central People’s Hospital,